These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 29269400)
1. LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells. Yue Z; Yuan Z; Zeng L; Wang Y; Lai L; Li J; Sun P; Xue X; Qi J; Yang Z; Zheng Y; Fang Y; Li D; Siwko S; Li Y; Luo J; Liu M FASEB J; 2018 May; 32(5):2422-2437. PubMed ID: 29269400 [TBL] [Abstract][Full Text] [Related]
2. R-spondin 2-LGR4 system regulates growth, migration and invasion, epithelial-mesenchymal transition and stem-like properties of tongue squamous cell carcinoma via Wnt/β-catenin signaling. Zhang L; Song Y; Ling Z; Li Y; Ren X; Yang J; Wang Z; Xia J; Zhang W; Cheng B EBioMedicine; 2019 Jun; 44():275-288. PubMed ID: 31097406 [TBL] [Abstract][Full Text] [Related]
3. The Role of LGR4 (GPR48) in Normal and Cancer Processes. Ordaz-Ramos A; Rosales-Gallegos VH; Melendez-Zajgla J; Maldonado V; Vazquez-Santillan K Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946652 [TBL] [Abstract][Full Text] [Related]
4. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
5. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. Luo W; Tan P; Rodriguez M; He L; Tan K; Zeng L; Siwko S; Liu M J Biol Chem; 2017 Sep; 292(37):15525-15537. PubMed ID: 28768769 [TBL] [Abstract][Full Text] [Related]
6. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis. Zuo Y; Ulu A; Chang JT; Frost JA Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144 [TBL] [Abstract][Full Text] [Related]
7. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling. Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949 [TBL] [Abstract][Full Text] [Related]
8. GPNMB augments Wnt-1 mediated breast tumor initiation and growth by enhancing PI3K/AKT/mTOR pathway signaling and β-catenin activity. Maric G; Annis MG; MacDonald PA; Russo C; Perkins D; Siwak DR; Mills GB; Siegel PM Oncogene; 2019 Jun; 38(26):5294-5307. PubMed ID: 30914799 [TBL] [Abstract][Full Text] [Related]
9. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
10. A Wnt-Independent LGR4-EGFR Signaling Axis in Cancer Metastasis. Yue F; Jiang W; Ku AT; Young AIJ; Zhang W; Souto EP; Gao Y; Yu Z; Wang Y; Creighton CJ; Nagi C; Wang T; Hilsenbeck SG; Feng XH; Huang S; Coarfa C; Zhang XH; Liu Q; Lin X; Li Y Cancer Res; 2021 Sep; 81(17):4441-4454. PubMed ID: 34099494 [TBL] [Abstract][Full Text] [Related]
11. The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling. Lopez Almeida L; Sebbagh M; Bertucci F; Finetti P; Wicinski J; Marchetto S; Castellano R; Josselin E; Charafe-Jauffret E; Ginestier C; Borg JP; Santoni MJ Stem Cell Reports; 2018 Nov; 11(5):1040-1050. PubMed ID: 30344009 [TBL] [Abstract][Full Text] [Related]
12. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer. Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204 [TBL] [Abstract][Full Text] [Related]
13. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis. Yue Z; Niu X; Yuan Z; Qin Q; Jiang W; He L; Gao J; Ding Y; Liu Y; Xu Z; Li Z; Yang Z; Li R; Xue X; Gao Y; Yue F; Zhang XH; Hu G; Wang Y; Li Y; Chen G; Siwko S; Gartland A; Wang N; Xiao J; Liu M; Luo J J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34847079 [TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Al-Dhfyan A; Alhoshani A; Korashy HM Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884 [TBL] [Abstract][Full Text] [Related]
15. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness. Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/β-Catenin signaling in breast cancer. Xie T; Jiang C; Dai T; Xu R; Zhou X; Su X; Zhao X Mol Carcinog; 2019 Oct; 58(10):1832-1845. PubMed ID: 31219645 [TBL] [Abstract][Full Text] [Related]
17. Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. Zhao Z; Lu P; Zhang H; Xu H; Gao N; Li M; Liu C Breast Cancer Res; 2014 Jul; 16(4):408. PubMed ID: 25056574 [TBL] [Abstract][Full Text] [Related]
18. RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling. Carmon KS; Gong X; Yi J; Thomas A; Liu Q Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1221-9. PubMed ID: 24639526 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway. Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855 [TBL] [Abstract][Full Text] [Related]
20. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]